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============

Escherichia coli NZRM4457 (originally ARL09/232) was the first New Delhi metallo-β-lactamase (NDM)-producing *Enterobacteriaceae* strain to be reported in New Zealand ([@B1]). The strain was isolated in 2009 from a urine sample from a patient who had been hospitalized in India and was repatriated to a New Zealand hospital 2 months later.

The E. coli NZRM4457 strain was obtained from the New Zealand Reference Culture Collection (Institute of Environmental Science and Research, New Zealand). We used a Qiagen UltraClean microbial DNA kit to extract genomic DNA from an overnight culture grown at 37°C in LB medium. The DNA sample was then submitted to the Massey Genome Service (Massey University, Palmerston North, New Zealand) for Illumina Nextera XT DNA library preparation and 2 × 150-base paired-end sequencing on the Illumina MiSeq platform. The resulting 3,261,556 reads (90× coverage) were trimmed of adapters using fastq-mcf v1.04.636 in ea-utils ([@B2]). Low-quality bases (Q scores of \<30) were trimmed and short reads (\<25 bp) were removed using SolexaQA++ v3.1.7.1 ([@B3]).

The long-read sequencing library was prepared from 1 μg DNA using an Oxford Nanopore Technologies (ONT) ligation sequencing kit (SQK-LSK109) according to the manufacturer's instructions. The sample was loaded onto a FLO-MIN106 R9.4.1 flow cell and sequenced on the MinION Mk1B platform, yielding 668,000 reads (5.2 Gbp \[977× coverage\]; mean read length, 5,794 bp). The reads were base called using ONT Guppy v3.4.5, and then the adapters were trimmed with Porechop v0.2.4 (<https://github.com/rrwick/Porechop>). FiltLong v0.2.0 (<https://github.com/rrwick/Filtlong>) was used to filter the reads by length (\>1,000 bp) and by quality (mean base Q score of \>10) and to discard the worst 10% of reads. The reads were randomly subsampled down to 500,003,523 bp (93× coverage) using seqtk v1.3-r106 (<https://github.com/lh3/seqtk>).

We used the Unicycler v0.4.8 pipeline ([@B4]) for hybrid assembly in normal mode, which resulted in nine circular contigs totaling 5,322,305 bp. The assembly was evaluated using Quast v5.0.2 ([@B5]), and genome completeness was assessed using BUSCO v4.0.5 ([@B6]) and CheckM v1.1.2 ([@B7]); 100% of conserved BUSCO genes in the enterobacterales_odb10 data set were recovered from the assembly, and the assembly was 99% complete according to CheckM using a taxonomy-specific workflow for Escherichia coli. The genome was then annotated using the NCBI Prokaryotic Genome Annotation Pipeline v4.11 ([@B8]).

The E. coli NZRM4457 genome consists of one chromosome and eight plasmids, which are described in [Table 1](#tab1){ref-type="table"}, with 5,125 coding sequences, 89 tRNAs, 22 rRNAs, and 10 noncoding RNAs. The plasmids were assigned to replicon types using PlasmidFinder v2.0.1 ([@B9]), and antimicrobial resistance genes were identified *in silico* using NCBI AMRFinder ([@B10]) and ResFinder v3.2 ([@B11]) ([Table 1](#tab1){ref-type="table"}). AMRFinder and ResFinder identified genes and mutations that confer resistance to β-lactams, fluoroquinolones, aminoglycosides, bleomycins, and sulfonamides. Additionally, chromosome-borne *nfsA* and *nfsB* were annotated as pseudogenes in E. coli NZRM4457, having internal nonsense (stop codon) and frameshift mutations, respectively. Mutations in *nfsA* and *nfsB* are implicated in nitrofuran resistance ([@B12], [@B13]), and we have verified the strain as being nitrofuran resistant (nitrofurantoin MIC, 128 μg/ml; furazolidone MIC, \>128 μg/ml) using the broth microdilution method, according to Clinical and Laboratory Standards Institute (CLSI) guidelines ([@B14]).

###### 

Characteristics of the genome of Escherichia coli NZRM4457

  Component    Size (bp)   G+C content (%)   Plasmid replicon type(s)                    Antimicrobial resistance gene(s)
  ------------ ----------- ----------------- ------------------------------------------- -------------------------------------------------------------------------------------------------
  Chromosome   4,836,724   50.9                                                          *bla*~EC~, *nfsA* mutation, *nfsB* mutation, *gyrA* (S83L, D87N), *parC* (S80I), *parE* (S458T)
  Plasmid 1    230,339     47.3              IncHI1A, IncHI1B                            *bla*~TEM-1~, *bla*~NDM-1~, *bla*~CTX-M-15~, *ble*
  Plasmid 2    139,294     51.2              IncC                                        *bla*~CMY-6~, *aac(6′)-Ib3*, *qacEdelta1*, *aph(3′)-Ia*, *rmtC*, *sul1*
  Plasmid 3    101,847     50.1              IncFII                                      *bla*~TEM-1~
  Plasmid 4    4,145       50.8              NI[^*a*^](#ngtab1.1){ref-type="table-fn"}   
  Plasmid 5    3,359       51.7              NI                                          
  Plasmid 6    2,883       49.7              NI                                          
  Plasmid 7    1,934       51.4              NI                                          
  Plasmid 8    1,780       56.6              ColpVC                                      
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NI, not identified using PlasmidFinder v2.0.1.

Data availability. {#s1.1}
------------------

The complete genome sequences of E. coli NZRM4457 have been deposited in GenBank under accession numbers [CP049967](https://www.ncbi.nlm.nih.gov/nuccore/CP049967), [CP049968](https://www.ncbi.nlm.nih.gov/nuccore/CP049968), [CP049969](https://www.ncbi.nlm.nih.gov/nuccore/CP049969), [CP049970](https://www.ncbi.nlm.nih.gov/nuccore/CP049970), [CP049971](https://www.ncbi.nlm.nih.gov/nuccore/CP049971), [CP049972](https://www.ncbi.nlm.nih.gov/nuccore/CP049972), [CP049973](https://www.ncbi.nlm.nih.gov/nuccore/CP049973), [CP049974](https://www.ncbi.nlm.nih.gov/nuccore/CP049974), and [CP049975](https://www.ncbi.nlm.nih.gov/nuccore/CP049975) and under BioProject [PRJNA611848](https://www.ncbi.nlm.nih.gov/bioproject/PRJNA611848). The raw reads were deposited into the NCBI Sequence Read Archive (SRA) under accession numbers [SRR11292825](https://www.ncbi.nlm.nih.gov/sra/SRR11292825) and [SRR11300819](https://www.ncbi.nlm.nih.gov/sra/SRR11300819).
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